Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig R Lee

Showing results (31-40 of 122) with videos related to

Pageof 13
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 16, 2010
Activation of the acute inflammatory response alters cytochrome P450 expression and eicosanoid metabolismKatherine N Theken, Yangmei Deng, M Alison Kannon, et al.
Plos One|April 16, 2013
Role of endothelial soluble epoxide hydrolase in cerebrovascular function and ischemic injuryWenri Zhang, Catherine M Davis, Matthew L Edin, et al.
Pharmacogenomics and Personalized Medicine|August 22, 2020
Clinical Utility of CYP2C19 Genotype-Guided Antiplatelet Therapy in Patients at Risk of Adverse Cardiovascular and Cerebrovascular Events: A Review of Emerging EvidenceMegan N Gower, Lindsay R Ratner, Alexis K Williams, et al.
Journal of Clinical Pharmacology|January 11, 2003
Tolbutamide, flurbiprofen, and losartan as probes of CYP2C9 activity in humansCraig R Lee, John A Pieper, Reginald F Frye, et al.
Pharmacogenomics|July 27, 2017
CYP2C19-guided antiplatelet therapy: a cost-effectiveness analysis of 30-day and 1-year outcomes following percutaneous coronary interventionMrudula S Borse, Olivia M Dong, Melissa J Polasek, et al.
European Journal of Clinical Pharmacology|April 17, 2003
Differences in flurbiprofen pharmacokinetics between CYP2C9*1/*1, *1/*2, and *1/*3 genotypesCraig R Lee, John A Pieper, Reginald F Frye, et al.
Human Molecular Genetics|August 24, 2005
The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic strokeMyriam Fornage, Craig R Lee, Peter A Doris, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 19, 2020
Cost-Effectiveness of Multigene Pharmacogenetic Testing in Patients With Acute Coronary Syndrome After Percutaneous Coronary InterventionOlivia M Dong, Stephanie B Wheeler, Gracelyn Cruden, et al.
American Heart Journal|June 2, 2007
Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fractionFrançois Alla, Ahmad Y Al-Hindi, Craig R Lee, et al.
Prostaglandins & Other Lipid Mediators|April 25, 2015
Soluble epoxide hydrolase null mice exhibit female and male differences in regulation of vascular homeostasisLuca Vanella, Martina Canestraro, Craig R Lee, et al.
Pageof 13

Showing results (31-40 of 122) with videos related to

Sort By:
Pageof 13
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 16, 2010
Activation of the acute inflammatory response alters cytochrome P450 expression and eicosanoid metabolismKatherine N Theken, Yangmei Deng, M Alison Kannon, et al.
Plos One|April 16, 2013
Role of endothelial soluble epoxide hydrolase in cerebrovascular function and ischemic injuryWenri Zhang, Catherine M Davis, Matthew L Edin, et al.
Pharmacogenomics and Personalized Medicine|August 22, 2020
Clinical Utility of CYP2C19 Genotype-Guided Antiplatelet Therapy in Patients at Risk of Adverse Cardiovascular and Cerebrovascular Events: A Review of Emerging EvidenceMegan N Gower, Lindsay R Ratner, Alexis K Williams, et al.
Journal of Clinical Pharmacology|January 11, 2003
Tolbutamide, flurbiprofen, and losartan as probes of CYP2C9 activity in humansCraig R Lee, John A Pieper, Reginald F Frye, et al.
Pharmacogenomics|July 27, 2017
CYP2C19-guided antiplatelet therapy: a cost-effectiveness analysis of 30-day and 1-year outcomes following percutaneous coronary interventionMrudula S Borse, Olivia M Dong, Melissa J Polasek, et al.
European Journal of Clinical Pharmacology|April 17, 2003
Differences in flurbiprofen pharmacokinetics between CYP2C9*1/*1, *1/*2, and *1/*3 genotypesCraig R Lee, John A Pieper, Reginald F Frye, et al.
Human Molecular Genetics|August 24, 2005
The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic strokeMyriam Fornage, Craig R Lee, Peter A Doris, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 19, 2020
Cost-Effectiveness of Multigene Pharmacogenetic Testing in Patients With Acute Coronary Syndrome After Percutaneous Coronary InterventionOlivia M Dong, Stephanie B Wheeler, Gracelyn Cruden, et al.
American Heart Journal|June 2, 2007
Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fractionFrançois Alla, Ahmad Y Al-Hindi, Craig R Lee, et al.
Prostaglandins & Other Lipid Mediators|April 25, 2015
Soluble epoxide hydrolase null mice exhibit female and male differences in regulation of vascular homeostasisLuca Vanella, Martina Canestraro, Craig R Lee, et al.
Pageof 13